Enhertu has now been granted five Breakthrough Therapy Designations, including three in breast cancer and one in both lung and gastric cancers
A Promising Innovative Medicine (PIM) designation is an early indication that leniolisib is a candidate for the MHRA's Early Access to Medicines Scheme
Biocon Biologics’ Insugen formulations will be available to patients at all Ministry of Health hospitals, district health offices and health clinics
Desidustat is currently approved only in India as OxemiaTM for patients with CKD induced anemia
Targeted action improves quality of healing of tendon and suspensory ligament injuries in horses
Rodolfo brings with him a wealth of rich experience from commercial, marketing, and general management roles across several multinational companies
The US $600 million acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients in Asia Pacific, Middle East and Africa
Researchers from the Tel Aviv University successfully engineer the world's first 3D human spinal cord tissue transplant
The recombinant nanoparticle-based rabies G protein vaccine is prepared using virus-like particle technology.
R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)
Subscribe To Our Newsletter & Stay Updated
